Skip to content

Clinical randomized controlled study of acupuncture-assisted gynecological tumor patients with immediate analgesia treated with after-loading acupuncture

Clinical randomized controlled study of acupuncture-assisted gynecological tumor patients with immediate analgesia treated with after-loading acupuncture

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005534
Enrollment
Unknown
Registered
2022-01-12
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Oncology

Interventions

Acupuncture group:Acupuncture

Sponsors

Cancer Hospital Affiliated to University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Are aged = 18 years old 2.Female patients diagnosed with pelvic malignancies, mainly cervical cancer and endometrial cancer. 3. scheduled for brachytherapy. 4.agreement via written informed consent after being provided with an explanation regarding the purpose and characteristics of this study.

Exclusion criteria

Exclusion criteria: 1.Serious other diseases, including liver and kidney dysfunction, acute stroke, cardiovascular diseases such as heart failure, and patients with cardiac pacemakers. 2.Regular use of painkillers or use of other pain relieving medicine on the day of the brachytherapy. 3. Known hypersensitive reaction to acupuncture treatment or the inability to cooperate with the acupuncture procedure. 4.Abnormal skin conditions in specific areas that may prevent acupuncture treatment. 5.Having a tendency to bleed easily. 6.Patients with history of syncope or seizure. 7. Patients who do not agree to clinical trials or those who have participated in other clinical trials in hospital. 8.Other people deemed unsuitable for participation by the researcher and atients incapable of reading, understanding, and signing a written consent form (for example,people who are mentally retarded, blinded,illiterate, or foreigners).

Design outcomes

Primary

MeasureTime frame
VAS;

Secondary

MeasureTime frame
SDS;Nausea and vomiting;SAS;Bruggemann comfort scale (BCS);

Countries

China

Contacts

Public Contactshuangmei zhang

Cancer Hospital Affiliated to University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)

zhangshuangmei1992@163.com13819486255

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026